Hydrochlorothiazide Tablet
Product Images NDC 43353-717

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 43353-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 50mg (43353 0717 45)

Label for Hydrochlorothiazide 50 mg oral tablets, containing 45 tablets per package. The label includes storage instructions, manufacturer TEVA Czech Industries, a repackager Aphena Pharma Solutions - Tennessee, LLC, and indicates the product is prescription only (RX only).*

FDA Label Image

Bottle Label 25mg (43353 0719 60)

Label for Hydrochlorothiazide 25 mg oral tablets, containing 90 tablets per bottle. The product is labeled for prescription use only and manufactured by Teva Czech Industries s.r.o., with repackaging by Aphena Pharma Solutions - Tennessee, LLC. Storage instructions and barcodes are also visible on the label.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Hctz Structural Formula (Image 01)

Chemical structure diagram of Hydrochlorothiazide, showing its core bicyclic ring system with attached chlorine, sulfonamide, and amine groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.